ndos
6'4.5'',wide frame,acnecel,here to looksmax
- Joined
- Sep 14, 2022
- Posts
- 737
- Reputation
- 488
Some blog article I found:
What this presented in people is the following:
-Reduced emotional depth, emotional numbness
-Reduced HIGH feeling when listening to amazing music.
-Reduced HIGH after the gym.
-No cosy/warm/oxytocin feeling when hugging loved ones.
-Reduced sensation on skin, when running under hot water… You know that warm COSY feeling you get when you have a shower or hot bath, that feeling is completely BLUNTED.
-Reduced orgasm sensation/feeling in the gonads/lifeless. Normal functioning.
-Worse pumps in the gym.
-Blank mind feeling, nothingness.
So as majority of you probably already are aware of what PSSD is. It stands for Post-SSRI-Sexual Dysfunction, and is ruining millions of lives every single day.
Here’s an explanation of the leading theories behind PSSD:
“It is inhibition of dopamine receptors in general, particularly in and around the Raphe nucleus. Which is a small cluster of nuclei found in the brain stem. It’s main function is to release serotonin to the rest of the brain. SSSRI antidepressants are believed to act in these nuclei. They are not damaged, they are not desensitized, there is nothing wrong with dopamine binding, and it is more complicated than there just not being enough dopamine release into the synapse.
It is actually being inhibited. So it doesn’t just release too little as a continual problem, when levels increase, they increase by lower a percentage. This is the basis for much of what people experience in different ways, due to differing genes. The main idea is the dopamine release is being inhibited. So those other dopamine receptors down the line aren’t getting what they need.
Serotonin receptors inhibit dopamine. That is because they act as a method of regulation. The more serotonin that binds to the heteroreceptor, the more dopamine release is inhibited. This receptor accepts binding of different neurotransmitters in different places, which have different affects on it, including regulation of dopamine release.
So why is an excessive amount of serotonin in the synapse, binding to the heteroreceptor?
It is because the autoreceptor is releasing too much serotonin into the synapse. So we have to figure out why that is. The autoreceptor is regulated by the same neurotransmitter, in this case serotonin. So the amount of serotonin which binds to it, controls how much serotonin it releases. Serotonin is generally inhibitory. So the more activation of this receptor, the more it’s release of serotonin is inhibited.
The main cause of PSSD is the receiving part of the autoreceptor being desensitized. So the normal amount of serotonin that was the right amount to do the job, now causes LESS activation of the receptor, and therefore it’s inhibitory effect on serotonin release is INSUFFICIENT.
Our autoreceptors didn’t go back to normal. They are stuck in that desensitized state. So the normal amount of serotonin which has always been there is not enough to do the job.
So in order to get the same amount of activation you had before, you must have MORE serotonin there than is normal. You have to compensate for that lack of sensitivity.
It’s kind of like when a button on a remote wears out. The normal amount of pressure won’t send the signal. You have to press harder to get it to work. In the same way, we have to press harder on the autoreceptor.
Agonism is not the same as reuptake inhibition. The former just means there is more there, but it is taken up normally. The latter means it is not taken up normally, and it builds up too quickly, too much.
So an antagonist on the autoreceptor is going to exacerbate the very problem you have. You can’t press the button more softly. You need an agonist, to inhibit the release of the receptor the same amount it used to before you got PSSD.” — Sonny.
Ashwagandha causes:
Reduced activation of (post-synaptic) 5-HT1A receptors which causes the Opposite of the following below:
The study says this effect is reduced sensitivity of 5-HT1A and increased the sensitivity of 5-HT2 receptors, as measured by response to selective agonists of each.
My theory is that presynaptic 5HT1a or autoreceptors — which are independent units with different location by my understanding — do almost nothing, except inhibit serotonin when upregulated, which improves my motivation and emotional anhedonia (terrible motivation and emotional anhedonia when downregulated with Ashwagandha).
Stimulation of the 5‐HT2C receptor with 5‐HT2C agonists results in delay of ejaculation in male rats, whereas stimulation of post‐synaptic 5‐HT1A receptors results in shortening of ejaculation latency 7, leading to the hypothesis that men with premature ejaculation (PE) may have hyposensitivity of 5‐HT2C and/or hypersensitivity of the 5‐HT1A receptor.
Ashwagandha significantly enhances the sensitivity of 5 HT2 (serotonin-2) receptors in the brain and a reciprocal sub-sensitivity of the 5HT1A receptors (19). Enhanced sensitivity could indicate reduces binding, as over-stimulation of a receptor will reduce it’s sensitivity. 5-HT2 stimulation increases prolactin (5-HT2A) and ACTH (5-HT2C) release. This may indicate one of the mechanism at which ashwagandha is potently anti-cortisol, as it reduces 5-HT2C sensitivity, thus reducing cortisol synthesis.
What this presented in people is the following:
-Reduced emotional depth, emotional numbness
-Reduced HIGH feeling when listening to amazing music.
-Reduced HIGH after the gym.
-No cosy/warm/oxytocin feeling when hugging loved ones.
-Reduced sensation on skin, when running under hot water… You know that warm COSY feeling you get when you have a shower or hot bath, that feeling is completely BLUNTED.
-Reduced orgasm sensation/feeling in the gonads/lifeless. Normal functioning.
-Worse pumps in the gym.
-Blank mind feeling, nothingness.
So as majority of you probably already are aware of what PSSD is. It stands for Post-SSRI-Sexual Dysfunction, and is ruining millions of lives every single day.
Here’s an explanation of the leading theories behind PSSD:
“It is inhibition of dopamine receptors in general, particularly in and around the Raphe nucleus. Which is a small cluster of nuclei found in the brain stem. It’s main function is to release serotonin to the rest of the brain. SSSRI antidepressants are believed to act in these nuclei. They are not damaged, they are not desensitized, there is nothing wrong with dopamine binding, and it is more complicated than there just not being enough dopamine release into the synapse.
It is actually being inhibited. So it doesn’t just release too little as a continual problem, when levels increase, they increase by lower a percentage. This is the basis for much of what people experience in different ways, due to differing genes. The main idea is the dopamine release is being inhibited. So those other dopamine receptors down the line aren’t getting what they need.
Serotonin receptors inhibit dopamine. That is because they act as a method of regulation. The more serotonin that binds to the heteroreceptor, the more dopamine release is inhibited. This receptor accepts binding of different neurotransmitters in different places, which have different affects on it, including regulation of dopamine release.
So why is an excessive amount of serotonin in the synapse, binding to the heteroreceptor?
It is because the autoreceptor is releasing too much serotonin into the synapse. So we have to figure out why that is. The autoreceptor is regulated by the same neurotransmitter, in this case serotonin. So the amount of serotonin which binds to it, controls how much serotonin it releases. Serotonin is generally inhibitory. So the more activation of this receptor, the more it’s release of serotonin is inhibited.
The main cause of PSSD is the receiving part of the autoreceptor being desensitized. So the normal amount of serotonin that was the right amount to do the job, now causes LESS activation of the receptor, and therefore it’s inhibitory effect on serotonin release is INSUFFICIENT.
Our autoreceptors didn’t go back to normal. They are stuck in that desensitized state. So the normal amount of serotonin which has always been there is not enough to do the job.
So in order to get the same amount of activation you had before, you must have MORE serotonin there than is normal. You have to compensate for that lack of sensitivity.
It’s kind of like when a button on a remote wears out. The normal amount of pressure won’t send the signal. You have to press harder to get it to work. In the same way, we have to press harder on the autoreceptor.
Agonism is not the same as reuptake inhibition. The former just means there is more there, but it is taken up normally. The latter means it is not taken up normally, and it builds up too quickly, too much.
So an antagonist on the autoreceptor is going to exacerbate the very problem you have. You can’t press the button more softly. You need an agonist, to inhibit the release of the receptor the same amount it used to before you got PSSD.” — Sonny.
Ashwagandha causes:
Reduced activation of (post-synaptic) 5-HT1A receptors which causes the Opposite of the following below:
- Increased sex drive, Increased REM sleep latency (takes longer to get to REM after falling asleep)
- Increased REM sleep latency (takes longer to get to REM after falling asleep)
- Increased sociability (likely mediated by increased Oxytocin)
- Peripheral vasodilation (outside the CNS)
- Analgesia (likely mediated by increased b-Endorphin)
- Anxiolysis
- Anti-depressant effects
- Reduced appetite
- Reduced aggression and impulsivity
- Interference with attention and vigilance at too high activation
- Increased secretion of Prolactin, Growth
The study says this effect is reduced sensitivity of 5-HT1A and increased the sensitivity of 5-HT2 receptors, as measured by response to selective agonists of each.
My theory is that presynaptic 5HT1a or autoreceptors — which are independent units with different location by my understanding — do almost nothing, except inhibit serotonin when upregulated, which improves my motivation and emotional anhedonia (terrible motivation and emotional anhedonia when downregulated with Ashwagandha).
Stimulation of the 5‐HT2C receptor with 5‐HT2C agonists results in delay of ejaculation in male rats, whereas stimulation of post‐synaptic 5‐HT1A receptors results in shortening of ejaculation latency 7, leading to the hypothesis that men with premature ejaculation (PE) may have hyposensitivity of 5‐HT2C and/or hypersensitivity of the 5‐HT1A receptor.
Ashwagandha significantly enhances the sensitivity of 5 HT2 (serotonin-2) receptors in the brain and a reciprocal sub-sensitivity of the 5HT1A receptors (19). Enhanced sensitivity could indicate reduces binding, as over-stimulation of a receptor will reduce it’s sensitivity. 5-HT2 stimulation increases prolactin (5-HT2A) and ACTH (5-HT2C) release. This may indicate one of the mechanism at which ashwagandha is potently anti-cortisol, as it reduces 5-HT2C sensitivity, thus reducing cortisol synthesis.